Integrated stepped alcohol treatment for patients with HIV and liver disease: A randomized trial
E. Jennifer Edelman(Yale University), David A. Fiellin(Yale University), Kendall Bryant(National Institute on Alcohol Abuse and Alcoholism), Amy C. Justice(Yale University), David Rimland(Emory University), Roger Bedimo(The University of Texas Southwestern Medical Center), Christopher J. Cutter(APT Foundation), Patrick G. O’Connor(Yale University), Michael S. Simberkoff(VA NY Harbor Healthcare System), Nathan B. Hansen(University of Georgia), Lynn E. Fiellin(Yale University), Vincent C. Marconi(Emory University), Janet P. Tate(Yale University), Cynthia L. Gibert(George Washington University), Maria C. Rodriguez‐Barradas(Michael E. DeBakey VA Medical Center), Stephen A. Maisto(Syracuse University), Yanhong Deng(Sun Yat-sen University)
Cited by 24
Related Papers
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k
Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
|The Lancet HIV|2023|506
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
|Clinical Cancer Research|2018|456